SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (138)12/21/1997 8:23:00 PM
From: MarcG  Read Replies (1) of 857
 
Big blue chips sure have been the way to invest in the mid to late 90's. BMY was very doggy for 2 years, '92 & '93. The stock split this year, 2 for 1, at about $140 ( now equivalent to $70). I agree that if your strategy is "buy and hold, hold, and hold", you've got to stick with the quality names. BTW, we sold a very small percentage of our long-term BMY position recently in the mid 90's.

"Judging from past behavior", I wouldn't say HEB is so low. This is the time of year to trim the tree and write off
dead wood, so I agree, you should sell whatever you consider "low" and without
much potential for price appreciation next year. HEB is 242% above its 52 week low of 1 3/4 and 30% off its high of 5 1/2. I think a trading range is developing now that will last until there is specific news.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News